SUBSCRIBE
SUBSCRIBE
News   FDA

Genentech’s (JOBS) Psoriasis Drug Raptiva Gets FDA Warning

October 17, 2008 | 
1 min read
WASHINGTON, Oct 16 (Reuters) - U.S. health regulators have ordered strong black-box warnings for Genentech Inc's psoriasis drug, Raptiva, saying patients given the once-weekly injections are at risk for life-threatening infections.
FDA Approvals
Genentech, Inc.
MORE ON THIS TOPIC
Light at the end of railroad tunnel. Natural lighting.
FDA
UniQure snags May Day decision date for Huntington’s gene therapy after arduous year
November 2, 2026
 · 
2 min read
 · 
Heather McKenzie
A 3D rendering of white ceramic mortar and pestle, green medical cross emblem is affixed to the front of bowl. It represents the mixing and grinding raw ingredients.
Manufacturing
HHS clears compounding pharmacies to manufacture 6 unapproved peptides
October 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Insights
Stability, speed and strategy: Inside Australia’s early‑stage edge
October 29, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Staying ahead of your competitors. Accelerated development of the company. Innovation vision. Customized solution. Unique skills. Red paper plane and whites. 3d render
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
October 28, 2026
 · 
4 min read
 · 
Heather McKenzie